Cargando…

Triglyceride-Glucose Index and Cardiovascular Events in Kidney Transplant Recipients

INTRODUCTION: Kidney transplant recipients (KTRs) have an increased risk of cardiovascular (CV) events (CVEs) compared with the general population. The impact of insulin resistance on CV risk after transplantation is not well defined. METHODS: We tested whether triglyceride-glucose (TyG) index, a su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colladant, Mathilde, Chabannes, Melchior, Crepin, Thomas, Bamoulid, Jamal, Courivaud, Cécile, Ducloux, Didier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658270/ https://www.ncbi.nlm.nih.gov/pubmed/38025208 http://dx.doi.org/10.1016/j.ekir.2023.08.021

Ejemplares similares

Factors associated with humoral response after BNT162b2 mRNA COVID-19 vaccination in kidney transplant patients
por: Ducloux, Didier, et al.
Publicado: (2021)

Current vaccine strategies against SARS_CoV-2 only poorly protect kidney transplant recipients
por: DUCLOUX, Didier, et al.
Publicado: (2022)

Humoral response after BNT162b2 mRNA COVID-19 vaccination in patients on haemodialysis depends on immune status
por: Ducloux, Didier, et al.
Publicado: (2021)

Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis
por: Ducloux, Didier, et al.
Publicado: (2021)

Pre-transplant Thymic Function Predicts Is Associated With Patient Death After Kidney Transplantation
por: Courivaud, Cécile, et al.
Publicado: (2020)

Pre-transplant immune profile defined by principal component analysis predicts acute rejection after kidney transplantation
por: Gaiffe, Emilie, et al.
Publicado: (2023)

Reversible Fluindione-Induced Chronic Interstitial Nephritis
por: Crepin, Thomas, et al.
Publicado: (2016)

End-Stage Renal Disease-Related Accelerated Immune Senescence: Is Rejuvenation of the Immune System a Therapeutic Goal?
por: Ducloux, Didier, et al.
Publicado: (2021)

Posttransplant Immune Activation: Innocent Bystander or Insidious Culprit of Posttransplant Accelerated Atherosclerosis
por: Ducloux, Didier, et al.
Publicado: (2017)

ESRD-associated immune phenotype depends on dialysis modality and iron status: clinical implications
por: Ducloux, Didier, et al.
Publicado: (2018)

The Interleukin-6 Gene Promoter Polymorphism -174 and Atherosclerotic Events in Overweight Transplanted Patients
por: Bamoulid, Jamal, et al.
Publicado: (2011)

REGEN-Cov antibody combination to prevent COVID-19 infection in kidney transplant recipient without detectable antibody response to optimal vaccine scheme
por: Ducloux, Didier, et al.
Publicado: (2022)

Early Post-Transplant Red Blood Cell Transfusion Is Associated With an Increased Risk of Transplant Failure: A Nationwide French Study
por: Gaiffe, Emilie, et al.
Publicado: (2022)

Prevention of Post-Transplant Diabetes Mellitus: Towards a Personalized Approach
por: Ducloux, Didier, et al.
Publicado: (2022)

Should vaccination against COVID-19 be mandated in patients on the transplant waiting list?
por: Ducloux, Didier, et al.
Publicado: (2021)

Transfused Red Blood Cell Characteristics and Kidney Transplant Outcomes Among Patients Receiving Early Posttransplant Transfusion
por: Gaiffe, Emilie, et al.
Publicado: (2023)

Acute kidney injury in non-critical care setting: elaboration and validation of an in-hospital death prognosis score
por: Bamoulid, Jamal, et al.
Publicado: (2019)

Ratio of triglyceride to high-density lipoprotein cholesterol and risk of major cardiovascular events in kidney transplant recipients
por: Kim, Ji Eun, et al.
Publicado: (2019)

The role of the triglyceride (triacylglycerol) glucose index in the development of cardiovascular events: a retrospective cohort analysis
por: Li, Sangsang, et al.
Publicado: (2019)

Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome
por: Wang, Le, et al.
Publicado: (2020)

Triglycerides–glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease
por: Quiroga, Borja, et al.
Publicado: (2022)

The predictive value of the triglyceride—glucose index for cardiovascular events in patients with coronary chronic total occlusion
por: Li, Yingkai, et al.
Publicado: (2022)

Triglyceride-glucose index and estimated 10-year risk of a first hard cardiovascular event
por: Qu, Hua, et al.
Publicado: (2023)

Influence of the Triglyceride-Glucose Index on Adverse Cardiovascular and Cerebrovascular Events in Prediabetic Patients With Acute Coronary Syndrome
por: Guo, Qianyun, et al.
Publicado: (2022)

A promising tool: triglyceride–glucose index to stratify the risk of cardiovascular events in chronic kidney disease
por: Yildirim, Fatma, et al.
Publicado: (2022)

Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes
por: Tai, Shi, et al.
Publicado: (2022)

Correction to: Triglycerides–glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease
Publicado: (2023)

COVID-19–Related Collapsing Glomerulopathy in a Kidney Transplant Recipient
por: Lazareth, Hélène, et al.
Publicado: (2020)

Determinants of urgent start dialysis in a chronic kidney disease cohort followed by nephrologists
por: Tachikart, Amin, et al.
Publicado: (2023)

The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study
por: Barzegar, Niloofar, et al.
Publicado: (2020)

Conversion From Belatacept to Another Immunosuppressive Regimen in Maintenance Kidney-Transplantation Patients
por: Gouin, Anna, et al.
Publicado: (2020)

PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled study
por: Gaiffe, E., et al.
Publicado: (2019)

The Triglyceride-Glucose Index Can Predict Long-Term Major Adverse Cardiovascular Events in Turkish Patients With High Cardiovascular Risk
por: Hayıroğlu, Mert İlker, et al.
Publicado: (2022)

Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients
por: Alizargar, Javad, et al.
Publicado: (2020)

Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations
por: Tao, Li-Chan, et al.
Publicado: (2022)

Triglyceride glucose index: A new biomarker in predicting cardiovascular risk
por: Araújo, Susilane Pereira, et al.
Publicado: (2022)

Triglyceride and Glucose Index and Sex Differences in Relation to Major Adverse Cardiovascular Events in Hypertensive Patients Without Diabetes
por: Yang, Kun, et al.
Publicado: (2021)

Comparison of the Effects of Fasting Glucose, Hemoglobin A(1c), and Triglyceride–Glucose Index on Cardiovascular Events in Type 2 Diabetes Mellitus
por: Su, Wei-Yu, et al.
Publicado: (2019)

Triglyceride-Glucose Index is a Risk Marker of Incident COPD Events in Women
por: Zaigham, Suneela, et al.
Publicado: (2022)

Prognostic value of triglyceride glucose index in population at high cardiovascular disease risk
por: Cai, Xiao-ling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gofgve93v7vqlca28psmaopr4t